AG
HAE icon

Algert Global’s Haemonetics HAE Stock Holding History

Algert Global’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.52M Sell
46,970
-30,870
-40% -$1.98M 0.04% 675
2026
Q1 		$4.39M Buy
77,840
+870
+1% +$56.7K 0.07% 476
2025
Q4 		$6.17M Buy
+76,970
New +$5.17M 0.1% 358
2025
Q3 		– Sell
-30,520
Closed -$2.28M – 1216
2025
Q2 		$2.28M Buy
+30,520
New +$2.02M 0.05% 590
2024
Q3 		– Sell
-22,972
Closed -$1.9M – 1345
2024
Q2 		$1.9M Sell
22,972
-30,945
-57% -$2.72M 0.06% 481
2024
Q1 		$4.6M Buy
53,917
+32,390
+150% +$2.54M 0.18% 174
2023
Q4 		$1.84M Sell
21,527
-3,310
-13% -$286K 0.07% 440
2023
Q3 		$2.22M Buy
24,837
+12,690
+104% +$1.13M 0.1% 331
2023
Q2 		$1.03M Sell
12,147
-25,732
-68% -$2.18M 0.05% 650
2023
Q1 		$3.13M Buy
+37,879
New +$3.07M 0.15% 206
2022
Q4 		– Sell
-11,524
Closed -$853K – 1186
2022
Q3 		$853K Sell
11,524
-2,063
-15% -$148K 0.05% 607
2022
Q2 		$886K Sell
13,587
-910
-6% -$53.9K 0.07% 531
2022
Q1 		$917K Buy
14,497
+668
+5% +$36.3K 0.06% 561
2021
Q4 		$733K Buy
13,829
+1,700
+14% +$104K 0.09% 384
2021
Q3 		$856K Buy
+12,129
New +$765K 0.11% 311

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Algert Global's HAE Position: Q2 2026 in Review

Algert Global reduced its Haemonetics (HAE) stake by 40% in Q2 2026, selling an estimated $1.98M and leaving 46,970 shares worth $3.52M. The position accounts for 0.04% of the portfolio, ranked #675.

Algert Global first reported a position in HAE in Q3 2021 and has held it in 15 quarters since. The position peaked at $6.17M in Q4 2025. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Algert Global held 46,970 shares of Haemonetics worth $3.52M as of Q2 2026.
  • Algert Global sold 30,870 Haemonetics shares in Q2 2026, an estimated $1.98M.
  • Haemonetics made up 0.04% of Algert Global's portfolio in Q2 2026, its #675 holding.
  • Algert Global first reported a position in Haemonetics in Q3 2021 and has held it in 15 quarters since.
  • Algert Global's Haemonetics position peaked at $6.17M in Q4 2025.
  • 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.